Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies (Details Narrative)

v3.26.3
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Apr. 27, 2026
Jul. 14, 2025
Sep. 30, 2026
Sep. 30, 2025
Sep. 15, 2026
Dec. 31, 2025
Loss Contingencies [Line Items]            
Advance in partnership restricted cash     $ 380     $ 741
Partnership accrued advance     359     731
Contingent milestone payments     $ 178    
Loss contingency, damages sought, value $ 1,750          
Other Accrued Liabilities, Current         $ 375  
License Agreement [Member]            
Loss Contingencies [Line Items]            
Contingent milestone payments     20,000      
STADA Arzneimittel AG [Member]            
Loss Contingencies [Line Items]            
Partnership accrued advance   $ 1,000        
Advance in partnership restricted cash     $ 380     $ 741